Access cutting-edge cancer treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Access cancer specialists in San Diego at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
This Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), high-grade neuroendocrine cancer of any primary site, diffuse large B-cell lymphoma (DLBCL), and tumors with L-MYC or N-MYC amplification. Patients receive escalating doses of a GSPT1 molecular glue degrader MRT-2359 to determine safety, tolerability, maximum tolerated dose (MTD) and/or recommended Phase
Sponsor: Monte Rosa Therapeutics, Inc
Check if you qualify for this cancer clinical trial in San Diego, CA
If you're searching for cancer treatment options in San Diego, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.